Bundled Payments: Implications for Medical Device & Drug/Biologic Companies

Bundled Payments for Medical Technology

Perspectives on Medical Reimbursement By JR Associates Recently, the trade press and mainstream news have been paying a lot of attention to bundled payments. Stories have focused primarily on how this shift in medical reimbursement will affect patients, providers and payers. Payers and provider networks are creating internal systems to identify the cost of treating…

Read More »

Proposed Changes In MPFS IDE Clinical Trial Coverage Rule: Comments to CMS

Perspectives on Medicare Policies By JR Associates SUBJECT: Medicare Physician Fee Schedule Rule: Proposed Changes for the Process for Covering Items and Services in an Investigational Device Exemption (IDE), Centers for Medicare and Medicaid Services (CMS) 78 Fed. Reg. 43282, 43342-47, 43523-25 (July 19, 2013) OVERVIEW: JR Associates is concerned about CMS’ proposed changes to…

Read More »

ICD-10 Impact on Cardiac Rhythm Management Procedure Coding

ICD 10 Impact on Cardiac Rhythm Management

Perspectives on Medical Reimbursement Issues By JR Associates Whitepaper: Impact of ICD-10 on Coding and Reimbursement for Cardiac Rhythm Management Procedures Authors: • Beth Bontemps, MSN, RN, NP, CCS Senior Consultant, JR Associates, Inc. • Rayellen Gilles, Customer Experience, Wolters Kluwer Law & Business Summary: By October 1, 2013, all U.S. healthcare providers are required to…

Read More »

Amyvid & Alzheimers Lesson: FDA Approval Is Not A Coverage Guarantee

Perspectives on Medical Reimbursement By JR Associates The path to advancements in disease detection and treatment is notoriously complex, circuitous and costly. However, even after FDA approval, there are no guarantees of reimbursement through CMS coverage. This is an essential lesson in the case of Eli Lilly’s Amyvid PET scan imaging agent, which is used…

Read More »

Medical Device Innovation: Is a Code Necessary for Commercial Adoption?

Perspectives on Medical Reimbursement By JR Associates For some medical devices, more than one reimbursement pathway may be viable. And, as JR Associates recently explained to Medical Device Daily, that could be the case for the Dune MarginProbe – a system that delivers real-time breast cancer detection in the operating room, by helping surgeons assess…

Read More »

Coding For Hypothermia; Clarifying New Standards

Perspectives on Medical Reimbursement By JR Associates Reprinted from The Society of Critical Care Medicine Contributing Authors: Kim Norton* Managing Partner, Argenta Advisors Seattle, Washington, USA Judy Rosenbloom** President, JR Associates Reseda, California, USA George A. Sample, MD*** Washington Hospital Center Washington, D.C. In 2005, the American Heart Association published guidelines (Class IIa and IIb)…

Read More »